Registro:

Referencias:

• Salzman, E.W., Hirsch, J., The epidemiology, pathogenesis and natural history of venous thrombosis (1994), pp. 1275-1296. , Colman RW, Hirsh J, Marder VJ, Salzman EW, editors. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd ed. Philadelphia: Lippincott; De Stefano, V., Finazzi, G., Mannucci, P.M., Inherited Thrombophilia: Pathogenesis, Clinical Syndromes, and Management (1996) Blood, 87, pp. 3531-3544
• Andersen, B.S., Olsen, J., Oral Contraception and Factor V Leiden Mutation in Relation to Localization of Deep Vein Thrombosis (1998) Thrombo Res, 90, pp. 191-194
• Rosendaal, F.R., Koster, T., Vandenbroucke, J.P., High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) (1995) Blood, 85, pp. 1504-1508
• Ridker, P.M., Hennekens, C.H., Lindpaintner, K., Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men (1995) N Engl J Med, 332, pp. 912-917
• Bertina, R.M., Reitsma, P.H., Rosendaal, F.R., Resistance to activated Protein C and factor V Leiden as risk factor for venous thrombosis (1995) Thromb Haemost, 74, pp. 449-453
• Dahlback, B., Resistance to activated protein C caused by the factor V R506Q mutation is a common risk factor for venous thrombosis (1997) Thromb Haemost, 78, pp. 483-488
• De Stefano, V., Chiusolo, P., Paciaroni, K., Epidemiology of Factor V Leiden: Clinical implications (1998) Sem in Thromb Hemostas, 24, pp. 367-379
• Poort, S.R., Rosendaal, F.R., Reitsma, P.H., Bertina, R.M., A common genetic variation in the 3' untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis (1996) Blood, 88, pp. 3698-3703
• Ridker, P.M., Hennekens, C.H., Miletich, J.P., G20210 A mutation in prothrombin gene and risk of myocardial infarction, stroke and venous thrombosis ia a large cohort of US men (1999) Circulation, 99, pp. 999-1004
• Raoul, M., Mathonnet, F., Peltier, J.Y., Collet, C., Boucly, C., Van Amerongen, G., Mathieu, B., Mazancourt, P., An Improved Method for the Detection of the G20210A Transition in the Prothrombin Gene (1997) Thromb Res, 88, pp. 441-443
• De Stefano, V., Chiusolo, P., Paciaroni, K., Prevalence of the 677C to T mutation in the methylenetetrahydrofolate reductase gene in Italian patients with venous thrombo tic disease (1998) Thromb Haemost, 79, pp. 686-687
• Kluijtmans, L.A., Den Heijer, M., Reitsma, P.H., Heil, S.G., Blom, H.J., Rosendaal, F.R., Thermolabile methylentetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis (1998) Thromb Haemost, 79, pp. 254-258
• Margaglione, M., D'Andrea, G., D'Addedda, M., Giuliani, N., Cappucci, G., Iannaccone, L., Vecchione, G., Di Minno, G., The methylenetetrahydrofolate reductase T677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation (1998) Thromb Haemost, 79, pp. 907-911
• Akar, N., Akar, E., Misirlioglu, M., Avcu, F., Yalcin, A., Cin, S., Search for Genetic Factors Favoring Thrombosis in Turkish Population (1998) Thromb Res, 92, pp. 79-82
• Hepner, M., Roldan, A., Pieroni, G., Frontroth, J.P., Serviddio, R.M., Feliu Torrres, A., Sciuccati, G., Bonduel, M., Factor V Leiden Mutation in the Argentinian Population (1999) Thromb Haemost, 81, p. 989
• Lahiri, D.K., Nurnberger, J.I., A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies (1991) Nucleic Acids Research, 19 (19), p. 5444
• Bertina, R.M., Koeleman, B.P.C., Koster, T., Mutation in blood coagulation factor V associated with resistance to activated protein C (1994) Nature, 369, pp. 64-67
• Froost, P., Blom, H.J., Milos, R., GoyeTe, P., Shepard, C.A., MaThews, R.G., Boers, G.J.H., Rozen, R., A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase (1995) Nature Genet, 10, pp. 111-113
• Rodeghiero, F., ToseTo, A., The epidemiology of inherited thrombophilia: The VITA project (1997) Thromb Haemostas, 78, pp. 636-640
• Gomez Rioja, R., Cuesta, M., Garcia Munoz, M., Prevalence of the FV Leiden mutation in the Spanish population (1997) Thromb Haemostas, 77 (S), p. 224. , Abst
• Camacho Vanegas, O., Giusti, B., Restrepo Fernandez, C.M., Abbate, R., Pepe, G., Frequency of Factor V (FV) Leiden and C677T Methylenetetrahydrofolate Reductase (MTHFR) mutations in Colombians (1998) Thromb Haemost, 79, pp. 883-884
• Salomon, O., Steinberg, D.M., Zivelin, A., Gitel, S., Dardik, R., Rosenberg, N., Berliner, S., Seligsohn, U., Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment (1999) Arterioscler Thromb Vasc Biol, 19, pp. 511-518

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------